The ImproveCareNow registry: Prediction of 2-year nonremission in pediatric ulcerative colitis

Jonathan Van Hecke1, Gigi Veereman2, Koen Huysentruyt2

  • 1Geneeskunde en Farmacie, Vrije Universiteit Brussel (VUB), Brussels, Belgium.

Insights

Predictors of unfavorable pediatric ulcerative colitis (UC) course include higher disease severity and BMI z-score, and not using immunomodulators (IM) early on. These factors may guide early treatment strategies for UC patients.

Area of Science:

  • Pediatric Gastroenterology
  • Inflammatory Bowel Disease Research
  • Clinical Epidemiology

Background:

  • Pediatric ulcerative colitis (UC) poses challenges in predicting disease course.
  • Identifying early predictors of unfavorable outcomes is crucial for timely therapeutic intervention.

Purpose of the Study:

  • To define predictors of nonremission at 2 years post-diagnosis in pediatric UC patients.
  • To inform therapeutic strategies by identifying early indicators of disease severity.

Main Methods:

  • Retrospective analysis of prospectively collected data from ImproveCareNow (2007-2023).
  • Included 1290 pediatric UC patients (<18 years) with ≥2-year follow-up.
  • Used logistic regression to identify predictors of nonremission, defining remission as pediatric UC activity index (PUCAI) <10.

Main Results:

  • 30% of patients (390/1290) were not in remission at 2 years.
  • Higher PUCAI scores (mild, moderate, severe), increased BMI z-score, and non-use of immunomodulators (IM) at T1 predicted non-remission at T2.
  • Predictive ability was limited (AUC 0.599-0.621).

Conclusions:

  • Increasing disease severity (PUCAI), higher BMI z-score, and lack of early IM use are predictors of an unfavorable pediatric UC course.
  • These findings may guide therapeutic decisions shortly after diagnosis.
  • Further research may refine predictive models for pediatric UC.
Abstract

Related Concept Videos

Drugs for Treatment of Ulcerative Colitis in IBD01:29

Drugs for Treatment of Ulcerative Colitis in IBD

Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
524
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
1.0K
Predicting Products: SN1 vs. SN202:27

Predicting Products: SN1 vs. SN2

Nucleophilic substitution reactions of alkyl halides can proceed via an SN1 or an SN2 mechanism. While in SN2 reactions, the nucleophile attacks the substrate simultaneously as the leaving group departs, in SN1 reactions, the substrate first dissociates to give the carbocation intermediate. Various factors such as the structure of the substrate, the strength of the nucleophile, and the nature of the solvent promote one mechanism over the other.
With increased substitution on the alkyl halide,...
17.4K
Predicting Molecular Geometry02:27

Predicting Molecular Geometry

VSEPR Theory for Determination of Electron Pair Geometries
46.0K